There are many imported targeted drugs for lung cancer, such as gefitinib, ositinib, alectinib and so on.
1. Gefitinib: it is suitable for the first-line treatment of non-small cell lung cancer with sensitive mutation of EGFR gene, it may have side effects such as rash, itchy skin, diarrhea, etc., and is forbidden to those who are allergic to it, and it is usually necessary to do genetic test to judge the indication of the drug before using it.
2. Ositinib: It is suitable for the first-line treatment of non-small cell lung cancer with sensitive mutation of EGFR gene, and also suitable for non-small cell lung cancer with disease progression after resistance to one generation of EGFR-TKI drugs and the presence of EGFR T790M mutation, which may have side effects such as diarrhea, skin rash, skin dryness and so on, and is forbidden to those who are allergic to it, and genetic testing is required to be done before use.
3. Aleitinib: it is suitable for ALK-positive locally advanced or metastatic non-small cell lung cancer, there may be constipation, myalgia, nausea and other side effects, and is prohibited for those who are allergic to it, and it is recommended to take it with food according to the recommended dosage, and taking it on an empty stomach may reduce the efficacy of the drug.
In addition to the above targeted drugs, there are other targeted drugs, such as erlotinib, afatinib, etc. Each drug has its own indications, side effects and precautions, and it is recommended that patients choose and apply them under the guidance of doctors, and should not apply them by themselves.